Novartis (NVS) said to weight selling ritalin, clozaril, exelon drugs - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Novartis (NYSE: NVS) said to weight selling ritalin, clozaril, exelon drugs, according to Bloomberg headlines. The drugs could bring in over $300 million for the company.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exclusive: Novartis in talks to sell some central nervous system drugs - sources
- Equinix (EQIX) Announces $3.6B Acquisition of Data Center Portfolio from Verzion (VZ)
- ePlus (PLUS) to Acquire Consolidated Communications (CNSL) Enterprise Services Equipment, IT Services Business
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors, Spinoffs, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!